Amyloid-β fibrils accumulated in preeclamptic placentas suppress cytotrophoblast syncytialization

Read full text
Authors: Kaho Nishioka, Midori Ikezaki, Naoyuki Iwahashi, Miyu Arakawa, Momo Fukushima, Noa Mori, Mika Mizoguchi, Yuko Horiuchi-Tanizaki, Megumi Fujino, Takami Tomiyama, Yoshito Ihara, Kenji Uchimura
+2 more Kazuhiko Ino, Kazuchika Nishitsuji
Cited by: 1
References: 98

Abstract

Cerebral deposition of fibrillar amyloid-β (Aβ) is a pathological hallmark of Alzheimer's disease. Although Aβ is present in human placentas and accumulates in preeclamptic placentas characterized by poor placentation, the production and role of Aβ in the human placenta remain unclear. Because hypoxia in mid-to-late pregnancy is a risk for preeclampsia, we found that levels of hypoxia-inducible factor 1-α and β-secretase (BACE-1) increased concurrently with placental Aβ deposition in late-stage preeclamptic placentas. We also found that a human cytotrophoblast (CTB) model, BeWo cells, actually produced Aβ species and that hypoxia increased Aβ production and BACE-1 protein levels. Aβ42 fibrils inhibited CTB syncytialization, a critical step in maintaining pregnancy, by inducing loss of membrane localization of cell-cell adhesion molecules. Primary human CTBs confirmed these observations. Taken together, our results suggest that increased Aβ production in CTBs by hypoxia may lead to the formation of Aβ fibrils, which inhibit syncytiotrophoblast formation and are detrimental to pregnancy. Thus, our results reveal the novel role of Aβ fibrils in the pathogenesis of preeclampsia.

Fields of Study & Subjects

Alzheimer's disease research and treatments Pregnancy and preeclampsia studies Neurological Disease Mechanisms and Treatments

Publication details

Journal / source
Life Science Alliance
Publisher
Life Science Alliance, LLC
Volume
9
Issue
4
Pages
e202503453–e202503453
Publication date
20 January 2026
Language
EN